Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

embed
 plays        
How to Play
HintAnswer
Levodopa class
Trihexyphenidyl class
Benzotropine class
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
Fluphenzaine class
MOA: Central (brain) anti-cholinergic
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
Phenothiazine class
Carbamazepine class
Ropinirole class
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
Orphenadrine class
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
Carbidopa class
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Riluzole class
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
Use: alleviation of chorea if refractory to atypical
Use: Most effective drug in tx of Tourette's
P-kinetics: Start with a small dose
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
P-kinetics: Given PO. Loses effectiveness over time.
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
MOA: Preferential affinity for D3 family of receptors
Clonazepam class
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
Bromocriptine class
Apomorphine class
HintAnswer
Olanzapine class
P-kinetics: Start at low dose & gradually increase
Rasagiline class
SSRI class
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
Pergolide class
Use: alleviation of chorea
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
Carbidopa + levidopa (1:10 or 1:4)
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
Use: Similar to Pramipexole
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
Pramipexole class
Use: Gold standard in Parkinson's dz - most efficacious treatment
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
Procyclidine class
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
SE: Insomnia when taken late in the day
Reserpine class
Haloperidol class
Entacapone class
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
Tetrabenxine class
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
Biperiden class
Tolcapone class
MOA: Pure D2 receptor agonist
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
HintAnswer
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
Selegiline class
Use: depression associated with Huntington's disease
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
Use: prolong ALS survival by months
Amantadine class
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
MOA: D2 receptor agonist (partial D1 agonist)
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
Clonidine class
Quetiapine class
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
P-kinetics: Similar to Pramipexole
TCA class
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
Risperidone class
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
MOA: D1 and D2 receptor agonist
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
Butyrophenones class
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...

Extras

Created Oct 8, 2011ReportNominate
Tags:disorder, drug, movement